Improving the efficiency of behavioural change interventions for the prevention of lifestyle-induced cardio-metabolic disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004306

Enrollment

300

Registered

2012-08-13

Start date

2009-02-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66 R03 E78 R73 R79

Interventions

Group 1: Health profiling twice at beginning and end of study (6 months after start of intervention): blood analysis (lipid panel, hsCRP, fasting glucose), blood pressure, cardiorespiratory exercise t

Eligibility

Sex/Gender

All

Age

25 Years to No maximum

Inclusion criteria

Inclusion criteria: Sedentary, with < 1 hr of exercise / week

Exclusion criteria

Exclusion criteria: currently exercising at a level that equals or exceeds the intervention's intended volume and intensity, history of myocardial infarction, stroke, TIA or major surgery within the past 3 months, orthopedic limitations which prevent from participation in an exercise program, asthma or other lung disease which limits the ability to exercise at high intensity, pregnancy, drug or alcohol abuse uncontrolled or poorly controlled hypertension (SBP=160 mmHg and/or DBP=100 mmHg), uncontrolled or poorly controlled diabetes mellitus, impairments or conditions which are preventive of participation in an exercise program.

Design outcomes

Primary

Measure	Time frame
Adherence expressed as duration (duration of participant's use of the Telehealth tool), volume (volume of weekly exercise) and latency (time between final examination and date of participant's last login).	—

Secondary

Measure	Time frame
all end points assessed 6 months after beginning of the intervention: maximal oxygen uptake (VO2peak) measured via gas exchange analysis during ergometer based exercise testing. For the assessment of the PROCAM risk score: Total cholesterol, HDL, LDL, triglycerides, fasting glucose and hsCRP via standardized laboratory assays on venous blood samples taken in the morning following a 12-hour fast. Blood pressure measured via oscillometric method. Body composition (body fat mass, lean mass, body water) measured via multi-frequency phase-sensitive bioimpedance analysis.	—

Measure

Time frame

all end points assessed 6 months after beginning of the intervention: maximal oxygen uptake (VO2peak) measured via gas exchange analysis during ergometer based exercise testing. For the assessment of the PROCAM risk score: Total cholesterol, HDL, LDL, triglycerides, fasting glucose and hsCRP via standardized laboratory assays on venous blood samples taken in the morning following a 12-hour fast. Blood pressure measured via oscillometric method. Body composition (body fat mass, lean mass, body water) measured via multi-frequency phase-sensitive bioimpedance analysis.

—

Countries

Germany

Contacts

Public ContactLutz Kraushaar

Bielefeld University

lutz.kraushaar@adiphea.com49 7221 502318

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026